IL6 and COVID-19: Although current evidence indicated no worsened outcomes in neonates, higher levels of inflammatory markers including polymerase chain reaction and IL-6 were observed in pregnant patients with COVID-19, which positively correlate with severe COVID-19, indicating the need for liver function monitoring in pregnant patients with COVID-19.